Symptom exacerbation and adherence to antiretroviral therapy during the menstrual cycle: A pilot study

Infectious Diseases in Obstetrics and Gynecology

Volumn 2006, Issue , 2006, Pages

  Patel, Pinaki N ^a,b   Grimes, Richard M ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b KANSAS CITY UNIVERSITY OF MEDICINE AND BIOSCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANALYTIC METHOD; ANXIETY DISORDER; ARTHRALGIA; ARTICLE; BLOATING; BREAST TENDERNESS; CHILL; CONFUSION; CONTROLLED STUDY; DEPRESSION; DIARRHEA; FATIGUE; FEMALE; HAND PARESTHESIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MEMORY DISORDER; MENSTRUAL CYCLE; MUSCLE CRAMP; NAUSEA AND VOMITING; PAIN; PILOT STUDY; PREMENOPAUSE; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RASH; SIDE EFFECT; SKIN DEFECT; SLEEP DISORDER; VISUAL DISORDER; WEIGHT GAIN; XEROSIS; DRUG EFFECT; PATIENT COMPLIANCE; PHYSIOLOGY; QUESTIONNAIRE; VIROLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MENSTRUAL CYCLE; PATIENT COMPLIANCE; PILOT PROJECTS; QUESTIONNAIRES;

EID: 33645243423     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/IDOG/2006/14869     Document Type: Article

References (13)

1. Bartlett JG. Pocket Guide to Adult HIV/AIDS Treatment. January 2005. Found at http://hopkins-aids.edu/publications/pocketguide/pocketgd0105.pdf. Last accessed February 16, 2005.
2. Guidelines for the Use of Antiretroviral Agents in HIV-Intected Adults and Adolescents. http://hivatis.org, 2004. Last accessed February 16, 2005.
3. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine. 2000;133(1):21-30.
4. Tsasis P. Adherence assessment to highly active antiretroviral therapy. AIDS Patient Care and STDs. 2001;15(3):109-115.
5. Safren SA, Otto MW, Worth JL, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behaviour Research and Therapy. 2001;39(10):1151-1162.
6. Molassiotis A, Nahas-Lopez V, Chung WYR, Lam SWC, Li CKP, Lau TFJ. Factors associated with adherence to antiretroviral medication in HIV-infected patients. International Journal of STD & AIDS. 2002;13(5):301-310.
7. Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 2001;28(5):445-449.
8. Monforte AA, Lepri AC, Rezza G, et al. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. AIDS. 2000;14(5):499-507.
9. Kuyper LM, Wood E, Montaner JSG, Yip B, O'Connell JM, Hogg RS. Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-infected patients in a population-based cohort. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 2004;37(4):1470-1476.
10. Roberts KJ. Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care and STDs. 2000;14(3):155-168.
11. Cu-Uvin S, Wright DJ, Anderson D, et al. Hormonal levels among HIV-1-seropositive women compared with high-risk HIV-seronegative women during the menstrual cycle. Journal of Women's Health & Gender-Based Medicine. 2000;9(8):857-863.
12. Robinson RL, Swindle RW. Premenstrual symptom severity: impact on social functioning and treatment-seeking behaviors. Journal of Women's Health & Gender-Based Medicine. 2000;9(7):757-768.
13. Moos RH. Menstrual Distress Questionnaire Manual. Los Angeles, Calif: Western Psychological Services; 1991.